Drug Treats Hyperphosphatemia Without Binding Phosphate
In a phase 3 trial, tenapanor, which reduces paracellular phosphate transport in the intestine, lowered elevated serum phosphorus in patients on hemodialysis.
End-Stage Renal Disease
Burden, Access and Disparities in Kidney Disease
Kidney disease is a global public health problem, affecting over 750 million persons worldwide.1,2 The burden of kidney disease varies substantially across the world, as does its detection and treatment. In many settings, rates of kidney disease and the provision of its care are defined by socio-economic, cultural and political factors leading to significant disparities.3 World Kidney…
Microwave Ablation for SHPT May Offer Alternative to Parathyroidectomy
In a small study of hemodialysis patients with secondary hyperparathyroidism, microwave ablation achieved higher rates of the recommended target levels of intact parathyroid hormone.
Improving Dialysis for Undocumented Immigrants With ESRD
Many are calling for standard dialysis coverage for undocumented immigrants with end-stage renal disease.
Kidney Failure Risk Minimal Following Diabetes Diagnosis
In a Finnish study, the cumulative risk for end-stage renal disease among patients with newly diagnosed with type 2 diabetes was less than 1% at 20 years.
Benefits, Barriers to Exercise Examined for Patients With ESRD
Patients undergoing dialysis would like to be able to exercise to improve energy, strength
Flu-Like Illness Tied to Increased Relative Mortality in ESRD
1,000 deaths of kidney failure patients each year in US may be attributable to seasonal influenza.
Shared Decision-Making About Dialysis Initiation Needs to Improve
In a real-world study, patients’ preferences did not weigh heavily in clinicians’ decisions to initiate dialysis.
Novel Albuminuria Endpoints May Improve CKD Progression Trials
Two companion meta-analyses show that early changes in albuminuria can predict the risk for end-stage renal disease.
Hyperkalemia Increases Risk for Progression to ESRD
Elevated serum potassium levels increased the risk for end-stage renal disease by approximately 30%, independent of decline in estimated glomerular filtration rate.
Next post in Hyperkalemia
